Home >Neurology > Multiple Sclerosis

Multiple Sclerosis Treatment in Mumbai

Multiple sclerosis is the kind of diagnosis that changes how a person thinks about their future. It should not have to. MS is a chronic demyelinating disease of the central nervous system the immune system attacks the myelin sheath protecting nerve fibres, disrupting communication between the brain and the body. The course is unpredictable, but management has advanced dramatically.

At Shree Hospitals, our neurology team offers multiple sclerosis treatment in Mumbai built around early diagnosis, aggressive relapse management, and disease-modifying therapy that genuinely alters the disease trajectory. The goal is not just to manage what is happening now it is to protect your neurological function for the long term.

(24×7 Emergency Care)

1800-268-4000

(24×7 Emergency Care)

1800-268-4000

Our Approach in Managing Multiple Sclerosis

MS management has two distinct tracks running simultaneously: treating the current relapse and preventing the next one. Our MS specialist neurologist team in Mumbai, India, addresses both, but the long-term disease-modifying decision is the one that matters most for your neurological future.

Diagnosis — Meeting the McDonald Criteria

MS diagnosis requires demonstration of lesions disseminated in time and space. This is not a clinical impression it requires structured evidence.

MRI brain and spinal cord with gadolinium contrast the primary diagnostic tool
CSF analysis oligoclonal bands and IgG index supporting inflammatory demyelination
Visual evoked potentials for subclinical optic nerve involvement

Acute Relapse Management

A relapse or clinical attack represents active inflammation and should be treated promptly to shorten its duration and reduce residual disability.

High-dose IV Methylprednisolone (1g daily for 3–5 days) the standard of care
Plasma exchange (PLEX) for severe relapses unresponsive to steroids
Symptomatic management during relapse pain, bladder dysfunction, spasticity, fatigue

Disease-Modifying Therapy (DMT) — The Core Decision

Disease-modifying therapy selection is the most consequential decision in MS management. It must be made considering disease activity, MRI burden, relapse frequency, disability trajectory, and patient preference.

Relapse and Remission Monitoring

Annual MRI brain and spine to assess lesion burden and detect subclinical activity
Patient-reported outcomes fatigue, cognition, bladder, mood, sexual dysfunction
MRI activity in the absence of clinical relapse (radiological activity) guides therapy escalation decisions

Symptom Management — The Invisible Burden of MS

Relapse and remission cycles leave behind cumulative symptoms that significantly affect quality of life.

Spasticity - Baclofen, Tizanidine, physiotherapy
Fatigue - one of the most disabling MS symptoms, managed with Amantadine and structured fatigue management strategies
Bladder dysfunction - oxybutynin, intermittent self-catheterisation, urology co-management
Cognitive impairment - neuropsychological assessment and cognitive rehabilitation
Depression - managed actively, as it is present in over 50% of MS patients at some point

Multidisciplinary Rehabilitation

Physiotherapy for strength, balance, gait, and spasticity management
Occupational therapy for workplace adaptations and daily living aids
Neuropsychology for cognitive and emotional support
Nursing care coordination for complex DMT regimens and monitoring schedules

How to Identify Multiple Sclerosis?

MS is notoriously difficult to diagnose early because its symptoms mimic many other conditions and they come and go.

Features that should prompt neurological evaluation, particularly in young adults aged 20–40:

An episode of visual loss or eye pain that resolves over days to weeks
Weakness, heaviness, or clumsiness in one limb appearing and then partially or fully resolving
Sensory symptoms numbness, tingling, or a band-like tightening sensation around the trunk or limbs
Unusual fatigue that is out of proportion to any physical or emotional explanation
Balance problems, dizziness, or uncoordinated walking appearing episodically
Bladder urgency or frequency in a young person with no urological cause identified
Symptoms worsening temporarily with heat a hot shower, fever, or physical exertion (Uhthoff's phenomenon)

The pattern of relapse and remission symptoms that come and go, affecting different parts of the nervous system at different times is the signature of demyelinating disease. If this pattern sounds familiar, seek evaluation for multiple sclerosis treatment in Mumbai with a neurologist experienced in MS.

Important FAQs — Multiple Sclerosis

Is MS a fatal disease?

MS is rarely fatal directly. Life expectancy is near-normal for most patients. However, disability accumulation over time and complications in severe cases can affect long-term health significantly.

Who is most likely to develop MS?

MS most commonly affects women aged 20–40, though it can present at any age. It is more common in temperate climates but is increasingly diagnosed across India.

Can MS be cured?

There is currently no cure, but high-efficacy DMTs can dramatically reduce relapse rates and slow disability progression some patients go years without a relapse on the right therapy.

How often should MS patients have an MRI?

Typically once a year as part of treatment monitoring, or more frequently if new symptoms occur or therapy escalation is being considered.

Is pregnancy safe with MS?

Pregnancy itself often reduces relapse rates due to immune changes. The postpartum period carries elevated relapse risk. Certain DMTs require discontinuation before conception. Our team provides specific preconception counselling.

What is the difference between RRMS and PPMS?

Relapsing-Remitting MS involves discrete attacks followed by partial or full recovery. Primary Progressive MS involves gradual neurological worsening from onset without clear relapses. They have different treatment algorithm